![Randomised trial of pembrolizumab versus standard treatment in patients with recurrent or metastatic head and neck cancer - ecancer Randomised trial of pembrolizumab versus standard treatment in patients with recurrent or metastatic head and neck cancer - ecancer](https://cdn.ecancer.org/17873-m.jpg)
Randomised trial of pembrolizumab versus standard treatment in patients with recurrent or metastatic head and neck cancer - ecancer
![Kevin HARRINGTON | Institute of Cancer Research, London | Division of Radiotherapy and Imaging | Research profile Kevin HARRINGTON | Institute of Cancer Research, London | Division of Radiotherapy and Imaging | Research profile](https://i1.rgstatic.net/ii/profile.image/556535446872065-1509699798223_Q512/Kevin-Harrington-2.jpg)
Kevin HARRINGTON | Institute of Cancer Research, London | Division of Radiotherapy and Imaging | Research profile
![Kevin HARRINGTON | Institute of Cancer Research, London | Division of Radiotherapy and Imaging | Research profile Kevin HARRINGTON | Institute of Cancer Research, London | Division of Radiotherapy and Imaging | Research profile](https://www.researchgate.net/publication/359388167/figure/fig1/AS:1138994456870913@1648568848067/ATRi-potentiates-RT-mediated-antitumor-immune-response-A-Experimental-design-for-the_Q320.jpg)
Kevin HARRINGTON | Institute of Cancer Research, London | Division of Radiotherapy and Imaging | Research profile
![Amazon | Targeted Therapy for Cancer (Medicine) | Syrigos, Konstantinos N., Harrington, Kevin | Oncology Amazon | Targeted Therapy for Cancer (Medicine) | Syrigos, Konstantinos N., Harrington, Kevin | Oncology](https://m.media-amazon.com/images/I/51QTEJSRAGL._SX360_BO1,204,203,200_.jpg)
Amazon | Targeted Therapy for Cancer (Medicine) | Syrigos, Konstantinos N., Harrington, Kevin | Oncology
ESMO Immuno-Oncology Virtual Congress 2020 | #ESMOImmuno20 Virtual Congress: Prof. Kevin Harrington, Scientific Co-Chair, tells you why this event is so unique. Remember that ESMO Members register... | By ESMO - European
![Kevin Harrington, The Original Shark from Shark Tank and Inventor of The Infomercial Joins the Advisory Board of USARAD including its SecondOpinions.com® Division Kevin Harrington, The Original Shark from Shark Tank and Inventor of The Infomercial Joins the Advisory Board of USARAD including its SecondOpinions.com® Division](http://ww1.prweb.com/prfiles/2021/01/11/17654673/Kevin%20Harrington%200159%20AAA%202.jpeg)